← Every applicant
Onesource Specialty FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| LEVOTHYROXINE SODIUMNew drugMar 5, 2025POWDER, INTRAVENOUS |
| SUMATRIPTAN SUCCINATENew drugNov 21, 2024INJECTABLE, SUBCUTANEOUS |
| THIAMINE HYDROCHLORIDENew drugOct 29, 2024INJECTABLE, INJECTION |
| METHOHEXITAL SODIUMNew drugOct 3, 2024INJECTABLE, INJECTION |
| CARBOPROST TROMETHAMINENew drugJul 25, 2023INJECTABLE, INJECTION |
| ACETYLCYSTEINENew drugApr 19, 2023INJECTABLE, INTRAVENOUS |
| MYCOPHENOLATE MOFETIL HYDROCHLORIDENew drugDec 23, 2022INJECTABLE, INJECTION |